Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

232
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
232
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

20
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

56
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

139
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
139

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Music in medical education: A critical interpretive synthesis.

Medical education·2023
Same author

Low tropical diversity during the adaptive radiation of early land plants.

Nature plants·2022
Same author

A review of the characteristic of "Grit" for emergency medicine resident selection and training: Making the intangible tangible?

The American journal of emergency medicine·2019
Same author

Calm amidst storm: Psychological skills and mindset training for maximizing performance in medical emergencies.

Resuscitation·2019
Same author

Bile Acid-Mediated Sphingosine-1-Phosphate Receptor 2 Signaling Promotes Neuroinflammation during Hepatic Encephalopathy in Mice.

Frontiers in cellular neuroscience·2017
Same author

Chapter 6: The chaperone action of Clusterin and its putative role in quality control of extracellular protein folding.

Advances in cancer research·2009

Related Experiment Video

Updated: Aug 20, 2025

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
09:23

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Published on: December 13, 2017

6.4K

High Sensitivity Troponins.

Tyler Thomas Hempel1, Amy Wyatt1

  • 1Department of Emergency Medicine, UPMC Harrisburg, 205 South Front Street, Brady 3 Suite 3A, Harrisburg, PA 17104, USA.

Emergency Medicine Clinics of North America
|November 17, 2022
PubMed
Summary

High-sensitivity cardiac troponin (hs-cTn) assays rapidly detect myocardial injury, aiding in ruling out non-ST-elevation myocardial infarction. Implementing validated hs-cTn protocols can reduce adverse cardiac events and improve emergency department efficiency.

Keywords:
Acute MIAcute coronary syndromeCardiac biomarkersCardiac rule outChest painEmergency medicineHigh-sensitivity troponinMyocardial infarction

More Related Videos

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

16.8K
Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

7.4K

Related Experiment Videos

Last Updated: Aug 20, 2025

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
09:23

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum

Published on: December 13, 2017

6.4K
A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

16.8K
Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training
07:40

Impact of High-intensity Interval Exercise and Moderate-Intensity Continuous Exercise on the Cardiac Troponin T Level at an Early Stage of Training

Published on: October 10, 2019

7.4K

Area of Science:

  • Cardiology
  • Biomarkers
  • Emergency Medicine

Background:

  • High-sensitivity cardiac troponin (hs-cTn) assays are crucial for detecting myocardial injury.
  • These assays are recommended by major US and European guidelines for cardiac biomarker assessment.
  • Rapid detection of myocardial injury is essential in emergency settings.

Purpose of the Study:

  • To highlight the role of hs-cTn assays in diagnosing myocardial infarction.
  • To emphasize the benefits of using validated hs-cTn protocols in clinical practice.
  • To discuss the downstream impacts of hs-cTn assay implementation on patient care and healthcare resource utilization.

Main Methods:

  • Review of current clinical guidelines and expert recommendations.
  • Analysis of the diagnostic capabilities of hs-cTn assays.
  • Evaluation of the clinical impact of hs-cTn assays on patient management and healthcare outcomes.

Main Results:

  • Hs-cTn assays demonstrate high specificity for cardiac tissue and rapid detection of myocardial injury.
  • In appropriate clinical contexts, hs-cTn assays facilitate rapid rule-out of non-ST-elevation myocardial infarction.
  • Implementation of hs-cTn assays can decrease 30-day major adverse cardiac events.

Conclusions:

  • Hs-cTn assays are vital tools for the rapid and accurate diagnosis of myocardial injury.
  • Standardized, validated hs-cTn protocols are recommended for institutional implementation.
  • Effective use of hs-cTn assays can optimize emergency department workflows, reduce hospitalizations, and improve patient outcomes.